fibrinogen has been researched along with Diseases, Metabolic in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Alolga, RN; Liu, Q; Liu, XH; Qi, LW | 1 |
| Chen, L; Fang, Y; Li, XM; Wang, X; Wang, YZ; Wei, SM; Wu, X; Yin, JS | 1 |
| Che, SL; Chen, L; Hou, XT; Li, F; Wang, L; Wang, WX; Yin, ZC; Zhang, H | 1 |
| Baj, Z; Kaczorowska, B; Pawelczyk, M | 1 |
| Krysiak, R; Okopień, B; Szkróbka, W | 1 |
| Doroslovački, R; Kupusinac, A; Malbaški, D; Srdić, B; Stokić, E | 1 |
| Dagnelie, PC; Derom, C; Gerver, WJ; Gielen, M; Houben, AJ; Loos, RJ; Mulder, AL; Stehouwer, CD; Touwslager, RN; Vlietinck, R; Zeegers, MP; Zimmermann, LJ | 1 |
| Aragno, M; Costelli, P; De Stefanis, D; Mastrocola, R; Nigro, D | 1 |
| Chen, H; Fillingim, RB; McEwen, BS; Nielsen, CS; Schirmer, H; Sibille, KT; Steingrímsdóttir, ÓA; Stubhaug, A | 1 |
| Araujo de Baptista, E; Baptista, T; Beaulieu, S; El Fakih, Y; Galeazzi, T; Rangel, N; Uzcátegui, E | 1 |
| ELLIOTT, KA; VAN GELDER, NM | 1 |
| Akyol, G; Cindoruk, M; Degertekin, B; Ekinci, O; Karakan, T; Simsek, Z; Unal, S | 1 |
| Barber, MD; Falconer, JS; Fearon, KC; McMillan, DC; Preston, T; Ross, JA | 1 |
| Andersen, P | 1 |
| Sherry, S | 1 |
| Bloch, P; Huguet, C; Levy, E; Loygue, J; Morisot, P | 1 |
| Quaglino, D; Storti, E | 1 |
5 review(s) available for fibrinogen and Diseases, Metabolic
| Article | Year |
|---|---|
Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: The need to harness its full potential.
Topics: Biomarkers, Tumor; Fibrinogen; Humans; Immunotherapy; Liver Diseases; Metabolic Diseases; Neoplasms | 2022 |
[Clinicopathological features of hepatic fibrinogen storage disease in children].
Topics: Child; Child, Preschool; China; Female; Fibrinogen; Humans; Liver; Liver Diseases; Male; Metabolic Diseases; Retrospective Studies | 2022 |
Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Amino Acids; Anorexia; Cachexia; Cytokines; Fibrinogen; Humans; Inflammation Mediators; Liver; Metabolic Diseases; Muscle, Skeletal; Nitrogen; Pancreatic Neoplasms; Protein Biosynthesis; Serum Albumin; Survival Rate; Weight Loss | 1999 |
Hypercoagulability and reduced fibrinolysis in hyperlipidemia: relationship to the metabolic cardiovascular syndrome.
Topics: Blood Coagulation; Cardiovascular Diseases; Cholesterol; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Lipoproteins, LDL; Metabolic Diseases; Plasminogen Inactivators; Syndrome | 1992 |
Fibrinolysis.
Topics: Alpha-Globulins; Biological Assay; Blood Coagulation Disorders; Blood Platelets; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Humans; Metabolic Diseases; Peptide Hydrolases; Plasminogen; Streptokinase; Thromboembolism; Thrombosis | 1968 |
2 trial(s) available for fibrinogen and Diseases, Metabolic
| Article | Year |
|---|---|
Different Effects of Atorvastatin on Cardiometabolic Risk Factors in Young Women With and Without Hyperprolactinemia.
Topics: Adult; Atorvastatin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperprolactinemia; Lipids; Metabolic Diseases; Middle Aged; Prolactin; Risk Factors | 2019 |
Rosiglitazone in the assistance of metabolic control during olanzapine administration in schizophrenia: a pilot double-blind, placebo-controlled, 12-week trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Double-Blind Method; Female; Fibrinogen; Hemoglobins; Humans; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Male; Metabolic Diseases; Middle Aged; Olanzapine; Pilot Projects; Rosiglitazone; Schizophrenia; Statistics as Topic; Thiazolidinediones | 2009 |
10 other study(ies) available for fibrinogen and Diseases, Metabolic
| Article | Year |
|---|---|
[Hepatic fibrinogen storage disease: a clinicopathological analysis of two cases].
Topics: Fibrinogen; Humans; Liver; Liver Diseases; Metabolic Diseases | 2023 |
Fibrinogen concentrations in ischaemic stroke patients with metabolic disorders.
Topics: Brain Ischemia; Cell-Derived Microparticles; Endothelial Cells; Fibrinogen; Humans; Metabolic Diseases; Stroke | 2020 |
A primary estimation of the cardiometabolic risk by using artificial neural networks.
Topics: Adolescent; Adult; Age Factors; Aged; Atherosclerosis; Blood Pressure; Body Mass Index; Female; Fibrinogen; Humans; Lipids; Male; Metabolic Diseases; Middle Aged; Neural Networks, Computer; Risk Factors; Sensitivity and Specificity; Sex Factors; Uric Acid; Waist-Hip Ratio | 2013 |
Genetic and environmental factors in associations between infant growth and adult cardiometabolic risk profile in twins.
Topics: Adolescent; Adult; Belgium; Blood Glucose; Blood Pressure; Child, Preschool; Environment; Female; Fibrinogen; Heart Diseases; Humans; Infant; Infant, Newborn; Insulin Resistance; Leptin; Lipids; Male; Metabolic Diseases; Prospective Studies; Risk Factors; Triglycerides; Twins; Twins, Dizygotic; Twins, Monozygotic; Weight Gain | 2013 |
Effects of chronic sugar consumption on lipid accumulation and autophagy in the skeletal muscle.
Topics: Animals; Autophagy; Beclin-1; Blood Glucose; Cholesterol; Disease Models, Animal; Fibrinogen; Fructose; Glucose; Insulin; Insulin Resistance; Interleukin-6; Lipid Metabolism; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Muscle, Skeletal; Suppressor of Cytokine Signaling 3 Protein; Triglycerides | 2017 |
Investigating the Burden of Chronic Pain: An Inflammatory and Metabolic Composite.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anthropometry; Body Mass Index; C-Reactive Protein; Chronic Pain; Female; Fibrinogen; Health Behavior; Humans; Inflammation; Male; Mental Health; Metabolic Diseases; Middle Aged; Norway; Pain Measurement; Risk Factors; Surveys and Questionnaires; Triglycerides | 2016 |
The state of factor I in rat brain: the effects of metabolic conditions and drugs.
Topics: Amino Acids; Animals; Brain; Fibrinogen; Metabolic Diseases; Rats | 1960 |
Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy.
Topics: Adult; Endoplasmic Reticulum; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Immunohistochemistry; Inclusion Bodies; Liver; Liver Cirrhosis; Metabolic Diseases; Microscopy, Electron; Necrosis | 2005 |
[Major hepatectomy in man. Metabolic consequences].
Topics: Adolescent; Adult; Ammonia; Bilirubin; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Blood Protein Disorders; Factor V; Factor VII; Factor X; Female; Fibrinogen; Fibrinolysis; Hematocrit; Hepatectomy; Humans; Hyperbilirubinemia; Lipids; Liver Neoplasms; Liver Regeneration; Male; Metabolic Diseases; Middle Aged; Postoperative Complications; Transaminases | 1972 |
Dysmetabolic and neurological complications in leukemia patients treated with L-asparaginase.
Topics: Asparaginase; Central Nervous System Diseases; Child; Clinical Enzyme Tests; Drug Hypersensitivity; Feeding and Eating Disorders; Female; Fibrinogen; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lipids; Male; Metabolic Diseases; Middle Aged; Nausea; Prothrombin Time; Uric Acid; Vomiting | 1970 |